hospital covid-19 Government patient

Medical Journal Lancet issues correction on study of COVID-19 and hydroxychloroquine trial

Reading now: 490
www.livemint.com

London: Medial journal The Lancet issued a correction on a large observational study that linked use of anti-malarial drug hydroxychloroquine with increased death risk in COVID-19 patients, after more than 100 scientists and medical professionals raised questions about integrity of data analysed in the study.

The study published on May 22 led the World Health Organization to temporarily suspend the trial of hydroxychloroquine on COVID-19 patients.

In the correction issued on Friday, Lancet said that one hospital self-designated as belonging to the Australasia continental designation should have been assigned to the Asian continental designation.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA